LOW-DOSE METHOTREXATE KINETICS IN ARTHRITIS

被引：84
作者：
EDELMAN, J
BIGGS, DF
JAMALI, F
RUSSELL, AS
机构：
[1] UNIV ALBERTA,FAC MED,DIV RHEUMATOL,EDMONTON T6G 2E1,ALBERTA,CANADA
[2] UNIV ALBERTA,FAC PHARM & PHARMACEUT SCI,EDMONTON T6G 2E1,ALBERTA,CANADA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 35卷 / 03期
关键词：
D O I：
10.1038/clpt.1984.47
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：382 / 386
页数：5
相关论文
共 22 条
[1]   PHARMACOKINETICS OF METHOTREXATE [J].
AZARNOFF, DL ;
WAN, SH ;
HUFFMAN, DH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 16 (05) :884-885
[2]   METHOTREXATE - CLINICAL PHARMACOLOGY, CURRENT STATUS AND THERAPEUTIC GUIDELINES [J].
BLEYER, WA .
CANCER TREATMENT REVIEWS, 1977, 4 (02) :87-101
[3]   THRESHOLD METHOTREXATE CONCENTRATION FOR IN-VIVO INHIBITION OF DNA-SYNTHESIS IN NORMAL AND TUMOROUS TARGET TISSUES [J].
CHABNER, BA ;
YOUNG, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (08) :1804-1811
[4]   DISPOSITION OF INTERMEDIATE-DOSE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA [J].
EVANS, WE ;
STEWART, CF ;
HUTSON, PR ;
CAIRNES, DA ;
BOWMAN, WP ;
YEE, GC ;
CROM, WR .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (11) :839-842
[5]  
FREEMANNARROD M, 1975, CANCER, V36, P1619, DOI 10.1002/1097-0142(197511)36:5<1619::AID-CNCR2820360514>3.0.CO
[6]  
2-G
[7]  
GIBALDI M, 1975, PHARMACOKINETICS
[8]  
HUFFMAN DH, 1973, CLIN PHARMACOL THER, V14, P572
[9]   PHARMACOKINETICS OF METHOTREXATE ADMINISTERED VIA THE HEPATIC-ARTERY [J].
IGNOFFO, RJ ;
OIE, S ;
FRIEDMAN, MA .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 5 (04) :217-220
[10]  
LEME PR, 1975, CANCER CHEMOTH REP 1, V59, P811
123